Volume 139, Issue 2, February 2013

ISSN: 0171-5216 (Print) 1432-1335 (Online)

In this issue (20 articles)

  1. Editorial

    Plagiarism revisited

    K. Höffken, H. Gabbert Page 179
    Download PDF (165KB) View Article

  2. No Access

    Original Paper

    Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening

    A. Caldarella, D. Puliti, E. Crocetti… Pages 181-185
    Look Inside Get Access

  3. No Access

    Original Paper

    Prognostic value of ERCC1 in head and neck carcinoma treated with definitive or adjuvant radiotherapy

    Vesna Bišof, Antonija Jakovčević… Pages 187-194
    Look Inside Get Access

  4. No Access

    Original Paper

    Plasma human neutrophil proteins-1, -2, and -3 levels in patients with bladder cancer

    Mustafa Gunes, Ilhan Gecit, Necip Pirincci… Pages 195-199
    Look Inside Get Access

  5. No Access

    Original Paper

    KRAS p.G13D mutations are associated with sensitivity to anti-EGFR antibody treatment in colorectal cancer cell lines

    Isabelle Messner, Giuseppe Cadeddu… Pages 201-209
    Look Inside Get Access

  6. No Access

    Original Paper

    A tumor hypoxic niche protects human colon cancer stem cells from chemotherapy

    Qin Mao, Yu Zhang, Xiaoyue Fu, Jianxin Xue… Pages 211-222
    Look Inside Get Access

  7. Original Paper

    Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

    Haiyan Si, Xiaoming Sun, Yingjian Chen… Pages 223-229
    Download PDF (312KB) View Article

  8. No Access

    Original Paper

    A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk

    Jun Chen, Reng-Yun Liu, Lixin Yang, Jun Zhao… Pages 231-242
    Look Inside Get Access

  9. No Access

    Original Paper

    Is helical tomotherapy accurate and safe enough for spine stereotactic body radiotherapy?

    Yoonsun Chung, Hong In Yoon, Joo Ho Kim… Pages 243-248
    Look Inside Get Access

  10. No Access

    Original Paper

    A nine-gene signature predicting clinical outcome in cutaneous melanoma

    G. Brunner, M. Reitz, A. Heinecke… Pages 249-258
    Look Inside Get Access

  11. No Access

    Original Paper

    Gene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancer

    Martin Koch, Michael Wiese Pages 259-267
    Look Inside Get Access

  12. Original Paper

    Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice

    Domenico Angelucci, Nicola Tinari… Pages 269-280
    Download PDF (646KB) View Article

  13. No Access

    Original Paper

    Neonatal suprarenal mass: differential diagnosis and treatment

    Wei Yao, Kai Li, Xianmin Xiao, Shan Zheng… Pages 281-286
    Look Inside Get Access

  14. No Access

    Original Paper

    Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential

    Hui Liu, Gang Chen, Wei Zhang, Jun-Yi Zhu… Pages 287-295
    Look Inside Get Access

  15. No Access

    Original Paper

    l-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients’ survival with stomach adenocarcinomas

    Dimitra Florou, Iordanis N. Papadopoulos… Pages 297-306
    Look Inside Get Access

  16. No Access

    Original Paper

    Prognostic value and differences of the sixth and seventh editions of the UICC/AJCC staging systems in nasopharyngeal carcinoma

    Rui Sun, Hui-Zhi Qiu, Hai-Qiang Mai… Pages 307-314
    Look Inside Get Access

  17. Original Paper

    Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb

    Debra T. Chao, Mian Su, Sonia Tanlimco… Pages 315-325
    Download PDF (729KB) View Article

  18. No Access

    Original Paper

    New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma

    Ilknur Kozanoglu, Melis Kartal Yandim… Pages 327-335
    Look Inside Get Access

  19. No Access

    Original Paper

    Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval

    Deniz Gencer, Salah-Eddin Al-Batran… Pages 337-345
    Look Inside Get Access

  20. No Access

    Original Paper

    Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary

    Dirk Bauerschlag, Karen Bräutigam… Pages 347-355
    Look Inside Get Access